. Thorax, 31,[149][150][151][152][153][154][155][156][157] 
Individuals with severe deficiency of the serum protein alpha-l-antitrypsin (alAT) were observed by Eriksson (1964) to have an increased liability to develop panacinar emphysema of early onset.
Further studies have shown that in an unselected population there exists a number of alAT 'vari- ants' or phenotypes which are determined by a system of multiple autosomal codominant alleles known as the Pi or protease inhibitor system (Fagerhol and Laurell, 1970) . More than 30 phenotypes have been described (Cook, 1974) , the allele products being named alphabetically accord-phenotype in Sweden would be 1 in 1750 of the population (Eriksson, 1965) compared with 1 in 3460 in England and Wales (Cook, 1974) .
It has been shown that alAT phenotype is an important factor in determining the concentration of aIAT in the serum, individuals with the Pi ZZ phenotype having a mean serum concentration only 15% of the average level found in Pi MM subjects (Ganrot. Laurell, and Eriksson, 1967) while the majority of other phenotypes show intermediate levels, the Pi MS and Pi MZ phenotypes having mean serum concentrations of 83 and 61% respectively of the mean Pi MM level (Fagerhol, 1969) . It would be of considerable epidemiological interest to know whether individuals of Pi MS and Pi MZ phenotype, who to- gether make up at least 10% of the populations described above, are more liable to develop emphysema than the majority with the phenotype Pi M. The objective of the present investigation is to compare pulmonary function and the prevalence of respiratory symptoms and chest illnesses between the Pi M, MS, and MZ phenotype groups in a large population.
MATERIAL AND METHODS
The subjects studied were 1995 working people in Northern Ireland, drawn from hospital workers, civil servants, factory and building site workers, and blood donors from many walks of life who were leading normal active working lives. They were 'self-selected' in the sense that they were informed of the nature and objectives of the study and then invited to participate. Only those over 35 years of age were approached because it was thought that below this age level symptoms or signs of incipient chronic airways obstruction might not yet have begun to show themselves. At interview the MRC questionnaire on respiratory symptoms (Medical Research Council, 1966 ) was completed and subsequently coded according to the definitions outlined in Appendix 1.' Each subject recorded five forced expiratory spirograms using a Vitalograph dry spirometer, the last three being averaged for one-second forced expired volume (FEV,) and forced vital capacity (FVC) while maximum mid-expiratory flow rate (MMF) was measured from the best of the five tracings. Gas volumes were corrected to BTPS.
A 10 ml venous blood sample was obtained from each subject, and the serum was analysed for al AT level by an automated immunoprecipitin technique using a Technicon AutoAnalyzer. Ali- ' The two appendices are available on application to Dr. R. B. Cole quots of pooled clear sera from 160 healthy adults of Pi M phenotype were deep frozen and served as a reference standard to which a value of 1000 was assigned. Alpha-l-antitrypsin phenotyping was carried out by acid starch gel electrophoresis using a modification of the method of Fagerhol (1968) and confirmed in every case by antigen-antibody crossed electrophoresis by a modification of the methods described by Ganrot (1972) . Further details of the electrophoretic methods used in this study are described elsewhere (Blundell et al., l 975b) .
Individuals heterozygous for the Pi-gene were identified by family studies which were completed only after the results of the survey had been analysed. Subjects of Pi M-phenotype have been included in the analysis with the Pi MM group which is therefore designated Pi M.
STATISTICAL ANALYSES All data were transferred to ICL 80 column punch cards. The data processing and the regression analyses described below were carried out on the Queen's University ICL 1906S and 1907 computers using ICL packages XDSD and XDS3. The conventional level of significance, P<0 05, has been used throughout.
Since the prevalences of the symptoms and chest illnesses considered (Appendix 1) may be influenced by age, area of residence (as a crude measure of atmospheric pollution), smoking habits, and exposure to dust during work, preliminary analyses (x2 tests) were carried out to determine whether the distribution of each of these factors, and of sex, height, and weight, differed significantly between the three phenotype groups; non-significance would justify the comparison of prevalences between phenotypes for all levels of the possible influencing factors combined. Because of the possibility of interactions between these factors a standardizing technique was applied, as described by Elwood et al. (1965) .
Because one of the principal features of the severely deficient alAT phenotype Pi ZZ is the onset of emphysema at a relatively early age (Eriksson, 1965) it seemed possible by analogy that a more rapid decline in pulmonary function with age might occur in the partially deficient Pi MS or Pi MZ phenotypes compared with the normal Pi M. In order to make this comparison the FEV,, FVC, and MMF values were standardized to a common height and regression coefficients of these standardized values on age were then derived for each phenotype, males and females separately, and also for certain subgroups classified according to current smoking habits or to exposure to dust during work. For each sex, these regression coefficients were compared between phenotypes using a well-known technique (eg, Quenouille, 1952; Snedecor and Cochran, 1968 Table I . (Table II) and frequency of previous chest illnesses (Table III) have therefore been tabulated according to the subjects' exposures to dust. Tables Ila and b suggest that for all subjects, irrespective of exposure to dust, and for subjects not exposed to dust the prevalences of breathlessness and wheezing are greatest in the Pi MZ group. However, no significant differences in prevalence between phenotypes were found for any of the four respiratory symptoms concerned. The small number of subjects exposed to dust, particularly in the Pi MS and MZ groups, prevented a formal comparison of the prevalences (Table lIc) . Table III shows the percentage number with a past history of bronchitis or emphysema for all subjects (Table Illa) , for subjects not exposed to dust (Table IlIb) , and for subjects exposed to dust ( Table IIIc) . The percentage with previous bronchitis or emphysema was greatest in the Pi MZ group but the differences were not statistically significant. A greater proportion of Pi MZ subjects compared to Pi M and MS subjects was found to have had a past history of pneumonia but again the phenotype differences were not significant. Furthermore, the percentage with a previous history of pleurisy did not differ significantly between the phenotypes.
The results of the standardization analysis confirmed that there were no significant differences between phenotype groups for either the respiratory symptoms of Table II or the chest illnesses  of Table III. PHYSIOLOGICAL VARIABLES Of the 1965 subjects of Pi M, MS, or MZ phenotype included in this study, 54 (2 7%) were omitted from the analysis of respiratory function because of deficiencies in the data, due to omissions in the questionnaires, unsatisfactory performance of the forced expiration or initial uncertainty in phenotyping (7 cases).
The following regression equations were derived from data relating to 'ideal normals', ie, asymptomatic Pi M subjects who had no serious chest illness and had never smoked or been exposed to toxic dust during work: Males (N= 184) FEV (1) all males and all females separately (Table   IV) ,
(2) males and females separately according to whether or not the subject was exposed to dust during work (Table Ia in Appendix 2) , and (3) males and females separately according to each subject's current smoking habits (Table  lb in Appendix 2). Many of these coefficients were already based on small numbers of readings, and this prevented a further breakdown into subgroups defined according to sex, exposure to dust, and current smoking habits simultaneously.
The vast majority of coefficients were negative as expected, but comparison of the slopes between phenotypes (Table Va, and Tables 2a and 3a in Appendix 2) revealed only one significant difference, namely, FVC on age in males exposed to dust which apeared to have arisen because of a positive coefficient found for Pi MS subjects. On the other hand, comparisons of the positions of the lines relating FEV,, FVC, and MMF to age showed some significant differences (Table Vb, and  Tables 2b and 3b in Appendix 2). The mean values of FEVy, FVC, and MMF adjusted to a common age within each comparison indicate the differences in positions of the lines for the three phenotypes (Table VI, and Tables 4a and b -0-0195±0-0119 -0-0165±0-0124 -0*0398±0-0270
Further tables relating to the groups subdivided according to dust exposure and smoking habits are included in Appendix 2 (Tables la and lb) . Further tables relating to the groups subdivided according to dust exposure and smoking habits are included in Appendix 2 (Tables 2 and 3) . Further tables relating to the groups subdivided according to dust exposure and smoking habits are included in Appendix 2 (Tables 4a and b) .
(see F values of Table Vb, and Tables 2b and 3b in Appendix 2). A similar trend was not readily apparent in the data for females.
DISCUSSION
The results of this study show that the distribution of Pi phenotypes in the working population of Northern Ireland, and the serum level of alAT for the different phenotypes, are similar to the results of population surveys in Norway (Fagerhol, 1967) and North America . They are also consistent with data for the rest of Britain described by Cook (1975) Webb et al. (1973) found no evidence that a history of pulmonary disease or respiratory symptoms was more common among MS or MZ subjects than MM subjects, and some further support for our findings comes from the large community study of Morse et al. (1975) , who were unable to show any correlation between respiratory symptoms, chest illness or pulmonary function and variations in serum trypsin inhibitory capacity which must in some measure have reflected the different alAT phenotypes in their population. However, quantitative methods for measuring a1AT in the serum, such as trypsin inhibitory capacity or immunodiffusion, have proved to be misleading as a means of distinguishing between different phenotypes (Talamo et al., 1972; Kanner et al., 1973) , and it is difficult to assess the significance of the numerous studies which have used quantitative methods as the basis for investigating the relationship between a1AT 'heterozygotes' and pulmonary disease (Lieberman, Mittman, and Schneider, 1969; Richardson et al., 1969; Welch et al., 1969 , Mittman et al., 1971 Resnick, Lapp, and Morgan, 1971) .
A more rigorous assessment can be made of those investigations in which the phenotypes of the individuals under scrutiny were reliably established either by antigen-antibody crossed electrophoresis or, in the case of Pi MZ subjects, as 'obligatory heterozygotes' because of their firstdegree relationship to Pi Z individuals. In three fairly small groups of obligatory heterozygotes, totalling 95 individuals in all, there was said to be no increased prevalence of pulmonary disease (Eriksson 1965; or evidence of severe emphysema (Hutchison, 1973) . Studying a series of 196 patients attending chest clinics for 'chronic' obstructive lung disease ', Fagerhol and Hauge (1969) found an unexpectedly high number of Pi SS, SZ, and ZZ phenotypes but not of Pi MZ, while Talamo et al. (1972) Barnett, Gottovi, and Johnsop (1975) found a significant excess of individuals of Pi MZ and ZZ phenotypes among 107 chest clinic patients with 'chronic obstructive lung disease' when compared with 97 control subjects. It seems likely that differences in the criteria for selection of patients must play some part in explaining these divergent results.
Turning to physiological tests of pulmonary function, some inconsistencies are apparent between the results of different investigators. The only study which, like our own, has compared tests of pulmonary function between large unselected but clearly identified phenotype groups similarly showed no significant difference between Pi M, MS, and MZ phenotypes using the simple measurements of function which can be derived from a forced expiratory spirogram. On the other hand, several investigations using a variety of more or less sophisticated tests to compare a carefully identified small group of Pi MZ individuals with a matched group of Pi M have described significant differences of function between these phenotypes. Ostrow and Cherniack (1972) compared 10 obligatory heterozygotes (Pi MZ) with 24 normal subjects well matched for age, sex, height, and smoking history but with an excess of symptomatic patients among the heterozygote group. They found no difference between the groups in subjects under 30 years of age, but in heterozygotes over 30 they found reduction in maximal expiratory flows and static elastic lung recoil, and some evidence of frequency dependence of compliance. Using routine tests of pulmonary function, Hall et al. (1973) Although partial alAT deficiency alone may have too slight a detrimental effect on the lung to be easily measured, it has been suggested that individuals of Pi MZ phenotype, and possibly of other phenotypes characterized by low alAT levels, may be more than usually susceptible to the harmful effects of inhaled materials such as cigarette smoke or dust (Mittman et al., 1971 The fact that the population studied consisted only of working people indicates that invalids, hospital patients, and the unemployed were excluded, and further implies that if individuals of Pi MS or MZ phenotype are highly concentrated among such groups the results of a truly random population study might differ from the results of the present investigation. The evidence for and against an excessive preponderance of Pi MZ subjects among chest clinic patients has been reviewed above, and it does not suggest that the distribution of phenotypes would be unduly biased by the exclusion of such patients from the population studied.
A population sample obtained by inviting the cooperation of individuals is subject to the criticism that those with symptoms or a family history of illness may avoid participation and so affect the validity of the sample. The observed prevalence of respiratory symptoms and of previous chest illness in the present study is consistent with other reports of the prevalence of chronic airways obstruction in Britain (eg, College of General Practitioners, 1961) and does not suggest that the sample studied differed in this respect from the general population.
Within these limitations we have found no evidence that individuals of Pi MS or MZ phenotype are more liable to show clinical or functional evidence of chronic airways obstruction than the bulk of the population of phenotype Pi M, and conclude that large-scale screening surveys to identify those who are unduly susceptible to pulmonary emphysema on the basis of their alAT phenotype would be of limited value since only the Pi Z phenotype, which occurs once in approximately 2300 individuals, has been shown unequivocally to be at special risk. 
